Finance

Lists
RUBICON:NSE
Rubicon Research Ltd
1 515,90 ₹
-0,49%
(-7,50) 1D
14 қаз., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for RUBICON...
Open
1 513,90 ₹
High
1 536,00 ₹
Low
1 483,40 ₹
Mkt. cap
250,93 млрд
Avg. vol.
237,50 м.
Volume
127,84 м.
Dividend
0,10%
Quarterly dividend
0,37 ₹
Ex-dividend date
2026 ж. 07 там.
P/E ratio
86,85
52-wk high
1 899,00 ₹
52-wk low
570,75 ₹
EPS
17,45 ₹
No. of employees
1 мың
Open
1 513,90 ₹
High
1 536,00 ₹
Low
1 483,40 ₹
Mkt. cap
250,93 млрд
Avg. vol.
237,50 м.
Volume
127,84 м.
Dividend
0,10%
Quarterly dividend
0,37 ₹
Ex-dividend date
2026 ж. 07 там.
P/E ratio
86,85
52-wk high
1 899,00 ₹
52-wk low
570,75 ₹
EPS
17,45 ₹
No. of employees
1 мың
News stories
From web sources and news partners
Simply Wall Street
Simply Wall Street
·
1 күн бұрын
3 Indian Growth Stocks With ROE Above 22%
Profile
Rubicon Research is an Indian pharmaceutical company located in Mumbai. The company has its corporate headquarters and R&D center in Thane, India, an R&D center in Concord, Canada, manufacturing plants located in Ambernath, Satara and Pithampur, India, and a regulatory office in East Windsor, US. Wikipedia
About Rubicon Research Ltd
CEO-
Employees1,29 мың
Founded1999
Headquarters-
SectorPharmaceutical industry
Last report
2026 ж. 14 там.
Fiscal period
Q1 2027
5,08 ₹ / 4,40 ₹
+15,45%beat
Revenue / Est. (INR)
5,34 млрд / 5,13 млрд
+4,20%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
4,12 млрд
4,76 млрд
5,14 млрд
5,34 млрд
Cost of goods sold
1,27 млрд
1,57 млрд
1,86 млрд
1,69 млрд
Cost of revenue
1,27 млрд
1,57 млрд
1,86 млрд
1,69 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
633,59 млн
663,73 млн
699,04 млн
856,66 млн
Operating expense
2,03 млрд
2,22 млрд
2,21 млрд
2,51 млрд
Total operating expenses
3,30 млрд
3,79 млрд
4,07 млрд
4,20 млрд
Operating income
824,26 млн
965,73 млн
1,06 млрд
1,14 млрд
Other non operating income
6,97 млн
37,87 млн
-157,07 млн
56,83 млн
EBT including unusual items
717,05 млн
905,86 млн
986,87 млн
1,10 млрд
EBT excluding unusual items
717,05 млн
905,86 млн
996,82 млн
1,10 млрд
Income tax expense
178,53 млн
177,89 млн
219,02 млн
255,91 млн
Effective tax rate
24,90%
19,64%
22,19%
23,19%
Other operating expenses
1,28 млрд
1,44 млрд
1,39 млрд
1,51 млрд
Net income
538,52 млн
727,97 млн
767,85 млн
847,81 млн
Net profit margin
13,07%
15,31%
14,94%
15,87%
Earnings per share
3,47
4,41
4,60
5,08
Interest and investment income
-
-
79,68 млн
-
Interest expense
-114,18 млн
-97,74 млн
-
-92,88 млн
Net interest expenses
-114,18 млн
-97,74 млн
79,68 млн
-92,88 млн
Depreciation and amortization charges
118,71 млн
115,53 млн
122,66 млн
151,39 млн
EBITDA
976,82 млн
1,12 млрд
1,14 млрд
1,21 млрд
Gain or loss from assets sale
7,63 млн
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары